Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Humulus lupulus extract, commonly known as hops extract, is a botanical ingredient derived from the female flowers (cones) of the hop plant. In the context of oral care, it is being developed by Procter & Gamble as an active component in dentifrice (toothpaste) formulations for the treatment and prevention of gingivitis. The extract contains bioactive compounds, primarily alpha-acids (humulones) and beta-acids (lupulones), which exhibit potent antimicrobial activity against key oral pathogens such as *Porphyromonas gingivalis*. Additionally, hops extract possesses anti-inflammatory properties, potentially reducing gingival inflammation by inhibiting pro-inflammatory mediators. Clinical evaluations have focused on its efficacy when formulated with fluoride sources to improve overall gingival health compared to standard stannous fluoride or sodium monofluorophosphate controls.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on humulus lupulus extract.